On February 12, Massachusetts-headquartered Ampersand Capital Partners announced its acquisition of Purna Pharmaceuticals. Purna Pharmaceuticals is an independent Belgian company established in 1986. The company provides contract services for the development and manufacturing of semi-solid, powders and liquid pharmaceutical products that meet GXP standards as well as specific customer-related requirements. […]
The post PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
